mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |